Animal NDC 0010-3142-01 Legend Multi Dose
Hyaluronate Sodium

Animal Product Information

Field Name Field Value
Animal NDC Code 0010-3142-01
Proprietary Name Legend Multi Dose What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Non-Proprietary Name Hyaluronate Sodium What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
Labeler Name Boehringer Ingelheim Animal Health Usa Inc.
Product Type Prescription Animal Drug
Usage Information
    INDICATIONS:LEGEND Multi Dose Injectable Solution is indicated in the treatment of joint dysfunction of the carpus or fetlock in horses due to non-infectious synovitis associated with equine osteoarthritis.
Active Ingredient(s)
  • Hyaluronate Sodium
Inactive Ingredient(s)
  • SODIUM CHLORIDE (451W47IQ8X)
  • SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM (GR686LBA74)
  • SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM (3980JIH2SW)
  • BENZYL ALCOHOL (LKG8494WBH)
  • SODIUM CHLORIDE (451W47IQ8X)
  • SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM (GR686LBA74)
  • SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM (3980JIH2SW)
  • BENZYL ALCOHOL (LKG8494WBH)
Marketing Category NADA - NEW ANIMAL DRUG APPLICATION What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
FDA Application Number NADA140883 What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

Legend Multi Dose Animal Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Table of Contents



Other



For intravenous use in horses only

Not for intra-articular use

20 mL

CAUTION:

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

CHEMISTRY:

Hyaluronic acid, a glycosaminoglycan, can exist in the following forms depending upon the chemical environment in which it is found: as the acid, hyaluronic acid; as the sodium salt, sodium hyaluronate (hyaluronate sodium); or as the hyaluronate anion. These terms may be used interchangeably but in all cases, reference is made to the glycosaminoglycan composed of repeating subunits of D-glucuronic acid and N-acetyl-D-glucosamine linked together by glycosidic bonds. Since this product originates from a microbial source, there is no potential for contamination with dermatan or chondroitin sulfate or any other glycosaminoglycan.

ANIMAL SAFETY WARNINGS:

Not for Intra-articular use. The Intra-articular safety of hyaluronate sodium with benzyl alcohol has not been evaluated.

Post-Approval Experience: While all adverse reactions are not reported, the following adverse reactions are based on voluntary post-approval reporting for LEGEND Injectable Solution: Occasional depression, lethargy, and fever.

To report suspected adverse events, for technical assistance or to obtain a copy of the Safety Data Sheet (SDS), contact Boehringer Ingelheim Animal Health USA Inc. at 1-888-637-4251. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS or online at www.fda.gov/reportanimalae.

EFFECTIVENESS:

Effectiveness studies utilizing LEGEND Multi Dose Injectable Solution were not performed. LEGEND Multi Dose Injectable Solution was approved based on the conclusion that the effectiveness of LEGEND Multi Dose Injectable Solution will not differ from that demonstrated for the original formulation of LEGEND Injectable Solution.

Twenty-one horses with lameness in either the carpal or fetlock joints were treated intravenously with LEGEND Injectable Solution in a well-controlled field study conducted at four locations. One, two or three injections were given based on clinical improvement. Overall clinical improvement was judged as excellent or good in 90% of the cases treated intravenously with LEGEND Injectable Solution.

ANIMAL SAFETY:

Animal safety studies utilizing LEGEND Multi Dose Injectable Solution were not performed. LEGEND Multi Dose Injectable Solution was approved based on the conclusion that the safety of LEGEND Multi Dose Injectable Solution will not differ from that demonstrated for the original formulation of LEGEND Injectable Solution.

LEGEND Injectable Solution was administered to normal horses at one, three and five times the recommended intravenous dosage of 40 mg. Treatments were given once weekly for nine consecutive weeks (three times the maximum duration). No systemic clinical signs were observed nor were there any adverse effects upon hematology or clinical chemistry parameters.

Approved by FDA under NADA # 140-883

Marketed by: Boehringer Ingelheim Animal Health USA Inc., Duluth, GA 30096

®LEGEND is a registered trademark and the horse logo is a trademark of Boehringer Ingelheim Animal Health USA Inc.
©2019 Boehringer Ingelheim Animal Health USA Inc.

1050-8683-03, Rev. 12-2019 86851121


Description



DESCRIPTION:

LEGEND Multi Dose Injectable Solution is a clear, colorless solution of low viscosity. LEGEND Multi Dose Injectable Solution is pyrogen free and sterile. It is administered by intravenous injection.

Hyaluronic acid, the conjugate acid of hyaluronate sodium, is extracted from the capsule of Streptococcus spp. and purified, resulting in a form which is essentially free of protein and nucleic acids.

LEGEND Multi Dose Injectable Solution is supplied in 20 mL vials. Each mL contains 10 mg hyaluronate sodium, 8.5 mg sodium chloride, 0.223 mg sodium phosphate dibasic, 0.04 mg sodium phosphate monobasic and 15.63 mg benzyl alcohol as a preservative. The pH is adjusted to between 6.5 and 8.0 with sodium hydroxide or hydrochloric acid.


Clinical Pharmacology



CLINICAL PHARMACOLOGY:

Hyaluronic acid is a naturally occurring substance present in connective tissue, skin, vitreous humour and the umbilical cord in all mammals. High concentrations of hyaluronic acid are also found in the synovial fluid. It also constitutes the major component of the capsule of certain microorganisms. The hyaluronic acid produced by bacteria is of the same structure and configuration as that found in mammals.

The actual mechanism of action for hyaluronate sodium in the healing of degenerative joint disease is not completely understood. One major function appears to be the regulation of normal cellular constituents. This effect decreases the impact of exudation, enzyme release and subsequent degradation of joint integrity. Additionally, hyaluronate sodium exerts an anti-inflammatory action by inhibiting the movement of granulocytes and macrophages.1 Hyaluronate molecules are long chains which form a filter network interspersed with normal cellular fluids.


Veterinary Indications



INDICATIONS:

LEGEND Multi Dose Injectable Solution is indicated in the treatment of joint dysfunction of the carpus or fetlock in horses due to non-infectious synovitis associated with equine osteoarthritis.


Dosage & Administration



DOSAGE AND ADMINISTRATION:

4 mL (40 mg) injected intravenously. Treatment may be repeated at weekly intervals for a total of three treatments.

Use aseptic technique and inject slowly into the jugular vein.

Horses should be given stall rest after treatment before gradually resuming normal activity.


Contraindications



CONTRAINDICATIONS:

There are no known contraindications for the use of LEGEND Multi Dose Injectable Solution in horses.


Residue Warning



RESIDUE WARNING:

Do not use in horses intended for human consumption.


Warnings



HUMAN WARNINGS:

Not for use in humans. Keep this and all other drugs out of reach of children.


Precautions



PRECAUTIONS:

Radiographic evaluation should be carried out in cases of acute lameness to ensure that the joint is free from serious fracture.

The safety of LEGEND Multi Dose Injectable Solution has not been evaluated in breeding stallions or in breeding, pregnant or lactating mares.


Adverse Reactions



ADVERSE REACTIONS:

No local or systemic side effects were observed in the field studies using LEGEND Injectable Solution.


Storage And Handling



STORAGE:

Store at or below 77°F (25°C). Brief excursions to 104°F (40°C) are permitted. Discard remaining product 6 months after first use.


How Supplied



HOW SUPPLIED:

LEGEND Multi Dose Injectable Solution is supplied in 20 mL bottles.


References



REFERENCE:

1Swanstrom, O.G. 1978. Hyaluronate (hyaluronic acid) and its use, Proc. American Assoc. Equine Pract., 24th annual convention, pp. 345-348.


Principal Display Panel - 20 Ml Bottle Carton



Legend® Multi Dose
(hyaluronate sodium)
Injectable Solution 10 mg/mL

For intravenous use in horses only
Not for intra-articular use

1 x 20 mL vial

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Approved by FDA under NADA # 140-883


* The information on this page is for an ANIMAL PRODUCT, please review the complete disclaimer below.